Clinical trial

A Short Term Open, Randomized Cross-over Trial Exploring the Effect of Carbonic Anhydrase Inhibition by Acetazolamide on Sleep Apnea Associated Hypertension and Vascular Dysfunction

NCT02220803

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Mapped RxNorm record Acetazolamide Normalized identity: acetazolamideView linked drug · Find medicine records · Find other trials using this name

DEVICE · Unmapped registry intervention nasal Continuous Positive Airway Pressure (nCPAP) Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

A Short Term Open, Randomized Cross-over Trial Exploring the Effect of Carbonic Anhydrase Inhibition by Acetazolamide on Sleep Apnea Associated Hypertension and Vascular Dysfunction

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE2

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2014-03-01

PhasePHASE2

Conditions

Obstructive Sleep Apneaverified · MONDO: obstructive sleep apnea syndrome

Sleep-Disordered Breathingverified · MONDO: sleep apnea syndrome

Blood Pressureunresolved

Hypertensionunresolved

Interventions

AcetazolamideDRUG · verified · RxNorm: acetazolamide

nasal Continuous Positive Airway Pressure (nCPAP)DEVICE

Sponsors & collaborators

Göteborg Universitylead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02220803 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.